Green FH: Overview of pulmonary fibrosis.
Chest 2002, 122:334S-339S.
Article
PubMed
Google Scholar
Demedts M, Wells AU, Anto JM, Costabel U, Hubbard R, Cullinan P, Slabbynck H, Rizzato G, Poletti V, Verbeken EK, Thomeer MJ, Kokkarinen J, Dalphin JC, Taylor AN: Interstitial lung diseases: an epidemiological overview.
Eur Respir J 2001, 32:2s-16s.
CAS
Google Scholar
American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial PneumoniasAm J Respir Crit Care Med 2002, 165:277–304.
Bouros D: Current classification of idiopathic interstitial pneumonias.
Monaldi Arch Chest Dis 2000, 55:450–454.
CAS
PubMed
Google Scholar
Noble PW: Idiopathic pulmonary fibrosis. New insights into classification and pathogenesis usher in a new era therapeutic approaches.
Am J Respir Cell Mol Biol 2003, 29:S27–31.
CAS
PubMed
Google Scholar
Collard HR, King TE Jr: Demystifying idiopathic interstitial pneumonia.
Arch Intern Med 2003, 163:17–29.
Article
PubMed
Google Scholar
Costabel U, King TE: International consensus statement on idiopathic pulmonary fibrosis.
Eur Respir 2001, 17:163–167.
Article
CAS
Google Scholar
Demedts M, Costabel U: ATS/ERS international multidisciplinary consensus classification of the idiopathic interstitial pneumonias.
Eur Respir J 2002, 19:794–796.
Article
CAS
PubMed
Google Scholar
Strieter RM: Pathogenesis and natural history of usual interstitial pneumonia: the whole story or the last chapter of a long novel.
Chest 2005, 128:526S-532S.
Article
PubMed
Google Scholar
Muller-Quernheim J: Sarcoidosis: immunopathogenetic concepts and their clinical application.
Eur Respir J 1998, 12:716–738.
Article
CAS
PubMed
Google Scholar
Strieter RM, Burdick MD, Gomperts BN, Belperio JA, Keane MP: CXC chemokines in angiogenesis.
Cytokine Growth Factor Rev 2005, 16:593–609.
Article
CAS
PubMed
Google Scholar
Strieter RM, Belperio JA, Keane MP: CXC chemokines in angiogenesis related to pulmonary fibrosis.
Chest 2002, 122:298S-301S.
Article
CAS
PubMed
Google Scholar
Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF: Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid.
Science219983–219985. 1983 Feb 25;
Shifren JL, Doldi N, Ferrara N, Mesiano S, Jaffe RB: In the human fetus, vascular endothelial growth factor is expressed in epithelial cells and myocytes, but not vascular endothelium: implications for mode of action.
J Clin Endocrinol Metab 1994, 79:316–322.
CAS
PubMed
Google Scholar
Koch AE, Harlow LA, Haines GK, Amento EP, Unemori EN, Wong WL, Pope RM, Ferrara N: Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis.
J Immunol 1994, 152:4149–4156.
CAS
PubMed
Google Scholar
Presta M, Dell'Era P, Mitola S, Moroni E, Ronca R, Rusnati M: Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis.
Cytokine Growth Factor Rev 2005, 16:159–178.
Article
CAS
PubMed
Google Scholar
Auguste P, Javerzat S, Bikfalvi A: Regulation of vascular development by fibroblast growth factors.
Cell Tissue Res 2003, 314:157–166.
Article
CAS
PubMed
Google Scholar
Streit M, Detmar M: Angiogenesis, lymphangiogenesis, and melanoma metastasis.
Oncogene 2003, 22:3172–3179.
Article
CAS
PubMed
Google Scholar
Pignolo RJ, Rotenberg MO, Cristofalo VJ: Analysis of EPC-1 growth state-dependent expression, specificity, and conservation of related sequences.
J Cell Physiol 1995, 162:110–118.
Article
CAS
PubMed
Google Scholar
Ohno-Matsui K, Yoshida T, Uetama T, Mochizuki M, Morita I: Vascular endothelial growth factor upregulates pigment epithelium-derived factor expression via VEGFR-1 in human retinal pigment epithelial cells.
Biochem Biophys Res Commun 2003, 303:962–967. 11
Article
CAS
PubMed
Google Scholar
Doll JA, Stellmach VM, Bouck NP, Bergh AR, Lee C, Abramson LP, Cornwell ML, Pins MR, Borensztajn J, Crawford SE: Pigment epithelium-derived factor regulates the vasculature and mass of the prostate and pancreas.
Nat Med 2003, 9:774–780.
Article
CAS
PubMed
Google Scholar
Strieter RM: Masters of angiogenesis.
Nat Med 2005, 11:925–927.
Article
CAS
PubMed
Google Scholar
Schruefer R, Lutze N, Schymeinsky J, Walzog B: Human neutrophils promote angiogenesis by a paracrine feedforward mechanism involving endothelial interleukin-8.
Am J Physiol Heart Circ Physiol 2005, 288:H1186–1192.
Article
CAS
PubMed
Google Scholar
Semenza GL: Involvement of hypoxia-inducible factor 1 in pulmonary pathophysiology.
Chest 2005, 128:592S-594S.
Article
CAS
PubMed
Google Scholar
Semenza GL: Oxygen-regulated transcription factors and their role in pulmonary disease.
Respir Res 2000, 1:159–162.
Article
CAS
PubMed
PubMed Central
Google Scholar
Daniels CE, Jett JR: Does interstitial lung disease predispose to lung cancer?
Curr Opin Pulm Med 2005, 11:431–437.
Article
PubMed
Google Scholar
Artinian V, Kvale PA: Cancer and interstitial lung disease.
Curr Opin Pulm Med 2004, 10:425–434.
Article
PubMed
Google Scholar
Sharma OP, Lamb C: Cancer in interstitial pulmonary fibrosis and sarcoidosis.
Curr Opin Pulm Med 2003, 9:398–401.
Article
PubMed
Google Scholar
Antoniou KM, Ferdoutsis E, Bouros D: Interferons and their application in the diseases of the lung.
Chest 2003, 123:209–216.
Article
CAS
PubMed
Google Scholar
Bouros D, Hatzakis K, Labrakis H, Zeibecoglou K: Association of malignancy with diseases causing interstitial pulmonary changes.
Chest 2002, 121:1278–1289.
Article
PubMed
Google Scholar
Ma Y, Seneviratne CK, Koss M: Idiopathic pulmonary fibrosis and malignancy.
Curr Opin Pulm Med 2001, 7:278–282.
Article
CAS
PubMed
Google Scholar
Samet JM: Does idiopathic pulmonary fibrosis increase lung cancer risk?
Am J Respir Crit Care Med 2000, 161:1–2.
Article
CAS
PubMed
Google Scholar
Fine A, Janssen-Heininger Y, Soultanakis RP, Swisher SG, Uhal BD: Apoptosis in lung pathophysiology.
Am J Physiol Lung Cell Mol Physiol 2000, 279:L423–427.
CAS
PubMed
Google Scholar
Murin S, Bilello KS, Matthay R: Other smoking-affected pulmonary diseases.
Clin Chest Med 2000, 21:121–137.
Article
CAS
PubMed
Google Scholar
Aubry MC, Myers JL, Douglas WW, Tazelaar HD, Washington Stephens TL, Hartman TE, Deschamps C, Pankratz VS: Primary pulmonary carcinoma in patients with idiopathic pulmonary fibrosis.
Mayo Clin Proc 2002, 77:763–770.
Article
PubMed
Google Scholar
Demopoulos K, Arvanitis DA, Vassilakis DA, Siafakas NM, Spandidos DA: MYCL1, FHIT, SPARC, p16(INK4) and TP53 genes associated to lung cancer in idiopathic pulmonary fibrosis.
J Cell Mol Med 2002, 6:215–222.
Article
CAS
PubMed
Google Scholar
Uematsu K, Yoshimura A, Gemma A, Mochimaru H, Hosoya Y, Kunugi S, Matsuda K, Seike M, Kurimoto F, Takenaka K, Koizumi K, Fukuda Y, Tanaka S, Chin K, Jablons DM, Kudoh S: Aberrations in the fragile histidine triad (FHIT) gene in idiopathic pulmonary fibrosis.
Cancer Res 2001, 61:8527–8533.
CAS
PubMed
Google Scholar
Yang JC, Haworth L, Sherry RM, Hwu P, Schwartzentruber DJ, Topalian SL, Steinberg SM, Chen HX, Rosenberg SA: A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer.
N Engl J Med 2003, 427–434. 31
Google Scholar
Noble PW: Idiopathic pulmonary fibrosis. New insights into classification and pathogenesis usher in a new era therapeutic approaches.
Am J Respir Cell Mol Biol 2003, 29:S27–31.
CAS
PubMed
Google Scholar
Turner-Warwick M: Precapillary systemic-pulmonary anastomoses.
Thorax 1963, 18:225–237.
Article
CAS
PubMed
PubMed Central
Google Scholar
Keane MP, Arenberg DA, Lynch JP 3rd, Whyte RI, Iannettoni MD, Burdick MD, Wilke CA, Morris SB, Glass MC, DiGiovine B, Kunkel SL, Strieter RM: The CXC chemokines, IL-8 and IP-10, regulate angiogenic activity in idiopathic pulmonary fibrosis.
J Immunol 1997, 159:1437–1443.
CAS
PubMed
Google Scholar
Keane MP, Belperio JA, Burdick MD, Lynch JP, Fishbein MC, Strieter RM: ENA-78 is an important angiogenic factor in idiopathic pulmonary fibrosis.
Am J Respir Crit Care Med 2001, 164:2239–2242.
Article
CAS
PubMed
Google Scholar
Meyer KC, Cardoni A, Xiang ZZ: Vascular endothelial growth factor in bronchoalveolar lavage from normal subjects and patients with diffuse parenchymal lung disease.
J Lab Clin Med 2000, 135:332–338.
Article
CAS
PubMed
Google Scholar
Koyama S, Sato E, Haniuda M, Numanami H, Nagai S, Izumi T: Decreased level of vascular endothelial growth factor in bronchoalveolar lavage fluid of normal smokers and patients with pulmonary fibrosis.
Am J Respir Crit Care Med 2002, 166:382–385.
Article
PubMed
Google Scholar
Renzoni EA, Walsh DA, Salmon M, Wells AU, Sestini P, Nicholson AG, Veeraraghavan S, Bishop AE, Romanska HM, Pantelidis P, Black CM, Du Bois RM: Interstitial vascularity in fibrosing alveolitis.
Am J Respir Crit Care Med 2003, 167:438–443.
Article
PubMed
Google Scholar
Cassan SM, Divertie MB, Brown AL Jr: Fine structural morphometry on biopsy specimens of human lung. Diffuse idiopathic pulmonary fibrosis.
Chest 1974, 65:275–278.
Article
CAS
PubMed
Google Scholar
Gracey DR, Divertie MB, Brown AL Jr: Alveolar-capillary membrane in idiopathic interstitial pulmonary fibrosis. Electron microscopic study of 14 cases.
Am Rev Respir Dis 1968, 98:16–21.
CAS
PubMed
Google Scholar
Ebina M, Shimizukawa M, Shibata N, Kimura Y, Suzuki T, Endo M, Sasano H, Kondo T, Nukiwa T: Heterogeneous increase in CD34-positive alveolar capillaries in idiopathic pulmonary fibrosis.
Am J Respir Crit Care Med 2004, 169:1203–1208.
Article
PubMed
Google Scholar
Renzoni EA: Neovascularization in idiopathic pulmonary fibrosis: too much or too little?
Am J Respir Crit Care Med 2004, 169:1179–1180.
Article
PubMed
Google Scholar
Cosgrove GP, Brown KK, Schiemann WP, Serls AE, Parr JE, Geraci MW, Schwarz MI, Cool CD, Worthen GS: Pigment epithelium-derived factor in idiopathic pulmonary fibrosis: a role in aberrant angiogenesis.
Am J Respir Crit Care Med 2004, 170:242–251.
Article
PubMed
Google Scholar
Keane MP: Angiogenesis and pulmonary fibrosis: feast or famine?
Am J Respir Crit Care Med 2004, 170:207–209.
Article
PubMed
Google Scholar
Belperio JA, Keane MP, Burdick MD, Gomperts B, Xue YY, Hong K, Mestas J, Ardehali A, Mehrad B, Saggar R, Lynch JP, Ross DJ, Strieter RM: Role of CXCR2/CXCR2 ligands in vascular remodeling during bronchiolitis obliterans syndrome.
J Clin Invest 2005, 115:1150–1162.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lappi-Blanco E, Kaarteenaho-Wiik R, Soini Y, Risteli J, Paakko P: Intraluminal fibromyxoid lesions in bronchiolitis obliterans organizing pneumonia are highly capillarized.
Hum Pathol 1999, 30:1192–1196.
Article
CAS
PubMed
Google Scholar
Lappi-Blanco E, Soini Y, Kinnula V, Paakko P: VEGF and bFGF are highly expressed in intraluminal fibromyxoid lesions in bronchiolitis obliterans organizing pneumonia.
J Pathol 2002,196(2):220–227.
Article
CAS
PubMed
Google Scholar
Nakayama S, Mukae H, Ishii H, Kakugawa T, Sugiyama K, Sakamoto N, Fujii T, Kadota J, Kohno S: Comparison of BALF concentrations of ENA-78 and IP10 in patients with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia.
Respir Med 2005, 99:1145–1151.
Article
PubMed
Google Scholar
Simler NR, Brenchley PE, Horrocks AW, Greaves SM, Hasleton PS, Egan JJ: Angiogenic cytokines in patients with idiopathic interstitial pneumonia.
Thorax 2004, 59:581–585.
Article
CAS
PubMed
PubMed Central
Google Scholar
Pignatti P, Brunetti G, Moretto D, Yacoub MR, Fiori M, Balbi B, Balestrino A, Cervio G, Nava S, Moscato G: Role of the Chemokine Receptors CXCR3 and CCR4 in Human Pulmonary Fibrosis.
Am J Respir Crit Care Med 2005 2006, 173:310–317.
Article
CAS
Google Scholar
Strieter RM, Starko KM, Enelow RI, Noth I, Valentine VG: Idiopathic Pulmonary Fibrosis Biomarkers Study Group. Effects of interferon-gamma 1b on biomarker expression in patients with idiopathic pulmonary fibrosis.
Am J Respir Crit Care Med 2004, 170:133–140.
Article
PubMed
Google Scholar
Tzouvelekis A, Kouliatsis G, Anevlavis S, Bouros D: Serum biomarkers in interstitial lung diseases.
Respir Res 2005, 6:78.
Article
PubMed
PubMed Central
Google Scholar
Peao MN, Aguas AP, de Sa CM, Grande NR: Neoformation of blood vessels in association with rat lung fibrosis induced by bleomycin.
Anat Rec 1994, 238:57–67.
Article
CAS
PubMed
Google Scholar
Keane MP, Belperio JA, Moore TA, Moore BB, Arenberg DA, Smith RE, Burdick MD, Kunkel SL, Strieter RM: Neutralization of the CXC chemokine, macrophage inflammatory protein-2, attenuates bleomycin-induced pulmonary fibrosis.
J Immunol 1999, 162:5511–5518.
CAS
PubMed
Google Scholar
Keane MP, Belperio JA, Arenberg DA, Burdick MD, Xu ZJ, Xue YY, Strieter RM: IFN-gamma-inducible protein-10 attenuates bleomycin-induced pulmonary fibrosis via inhibition of angiogenesis.
J Immunol 1999, 163:5686–5692.
CAS
PubMed
Google Scholar
Burdick MD, Murray LA, Keane MP, Xue YY, Zisman DA, Belperio JA, Strieter RM: CXCL11 attenuates bleomycin-induced pulmonary fibrosis via inhibition of vascular remodeling.
Am J Respir Crit Care Med 2005, 171:261–268.
Article
PubMed
Google Scholar
Hamada N, Kuwano K, Yamada M, Hagimoto N, Hiasa K, Egashira K, Nakashima N, Maeyama T, Yoshimi M, Nakanishi Y: Anti-vascular endothelial growth factor gene therapy attenuates lung injury and fibrosis in mice.
J Immunol 2005, 175:1224–1231.
Article
CAS
PubMed
Google Scholar
Jiang D, Liang J, Hodge J, Lu B, Zhu Z, Yu S, Fan J, Gao Y, Yin Z, Homer R, Gerard C, Noble PW: Regulation of pulmonary fibrosis by chemokine receptor CXCR3.
J Clin Invest 2004, 114:291–299.
Article
CAS
PubMed
PubMed Central
Google Scholar
Liu T, Nozaki Y, Phan SH: Regulation of telomerase activity in rat lung fibroblasts.
Am J Respir Cell Mol Biol 2002, 26:534–540.
Article
CAS
PubMed
Google Scholar
Antoniou KM, Alexandrakis MG, Sfiridaki K, Tsiligianni I, Perisinakis K, Tzortzaki EG, Siafakas NM, Bouros DE: Th1 cytokine pattern (IL-12 and IL-18) in bronchoalveolar lavage fluid (BALF) before and after treatment with interferon gamma-1b (IFN-gamma-1b) or colchicine in patients with idiopathic pulmonary fibrosis (IPF/UIP).
Sarcoidosis Vasc Diffuse Lung Dis 2004, 21:105–110.
PubMed
Google Scholar
Tsiligianni I, Antoniou KM, Kyriakou D, Tzanakis N, Chrysofakis G, Siafakas NM, Bouros D: Th1/Th2 cytokine pattern in bronchoalveolar lavage fluid and induced sputum in pulmonary sarcoidosis.
BMC Pulm Med 2005, 5:8.
Article
PubMed
PubMed Central
Google Scholar
Agostini C, Cassatella M, Zambello R, Trentin L, Gasperini S, Perin A, Piazza F, Siviero M, Facco M, Dziejman M, Chilosi M, Qin S, Luster AD, Semenzato G: Involvement of the IP-10 chemokine in sarcoid granulomatous reactions.
J Immunol 1998, 161:6413–6420.
CAS
PubMed
Google Scholar
Miotto D, Christodoulopoulos P, Olivenstein R, Taha R, Cameron L, Tsicopoulos A, Tonnel AB, Fahy O, Lafitte JJ, Luster AD, Wallaert B, Mapp CE, Hamid Q: Expression of IFN-gamma-inducible protein; monocyte chemotactic proteins 1, 3, and 4; and eotaxin in TH1- and TH2-mediated lung diseases.
J Allergy Clin Immunol 2001, 107:664–670.
Article
CAS
PubMed
Google Scholar
Katoh S, Fukushima K, Matsumoto N, Ehara N, Matsumoto K, Yamauchi A, Hirashima M: Accumulation of CXCR3-expressing eosinophils and increased concentration of its ligands (IP10 and Mig) in bronchoalveolar lavage fluid of patients with chronic eosinophilic pneumonia.
Int Arch Allergy Immunol 2005, 137:229–235.
Article
CAS
PubMed
Google Scholar
Sekiya M, Ohwada A, Miura K, Takahashi S, Fukuchi Y: Serum vascular endothelial growth factor as a possible prognostic indicator in sarcoidosis.
Lung 2003, 181:259–265.
Article
CAS
PubMed
Google Scholar
Luster AD: Chemokines – chemotactic cytokines that mediate inflammation.
N Engl J Med 1998, 338:436–45.
Article
CAS
PubMed
Google Scholar
Strieter RM, Belperio JA, Burdick MD, Sharma S, Dubinett SM, Keane MP: CXC chemokines: angiogenesis, immunoangiostasis, and metastases in lung cancer.
Ann N Y Acad Sci 2004, 1028:351–360.
Article
CAS
PubMed
Google Scholar
Phillips RJ, Burdick MD, Hong K, Lutz MA, Murray LA, Xue YY, Belperio JA, Keane MP, Strieter RM: Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis.
J Clin Invest 2004, 114:438–446.
Article
CAS
PubMed
PubMed Central
Google Scholar
Frankel SK, Cosgrove GP, Cha SI, Cool CD, Wynes MW, Edelman BL, Brown KK, Riches DW: TNF-{alpha} Sensitizes Normal and Fibrotic Human Lung Fibroblasts to Fas-induced Apoptosis.
Am J Respir Cell Mol Biol 2005 2006, 34:293–304.
Article
CAS
Google Scholar
Hashimoto N, Jin H, Liu T, Chensue SW, Phan SH: Bone marrow-derived progenitor cells in pulmonary fibrosis.
J Clin Invest 2004, 113:243–252.
Article
CAS
PubMed
PubMed Central
Google Scholar
Tager AM, Kradin RL, LaCamera P, Bercury SD, Campanella GS, Leary CP, Polosukhin V, Zhao LH, Sakamoto H, Blackwell TS, Luster AD: Inhibition of pulmonary fibrosis by the chemokine IP-10/CXCL10.
Am J Respir Cell Mol Biol 2004, 31:395–404.
Article
CAS
PubMed
Google Scholar
Tzouvelekis A, Patlakas G, Bouros D: Application of microarray technology in pulmonary diseases.
Respir Res 2004, 5:26.
Article
PubMed
PubMed Central
Google Scholar
Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G, Kallioniemi OP: Tissue microarrays for high-throughput molecular profiling of tumor specimens.
Nat Med 1998, 4:844–847.
Article
CAS
PubMed
Google Scholar